Analyst consensus rating
Immunocore Holdings Analyst Rating: Buy
Direct answer
Immunocore Holdings's consensus rating is Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $59.40.
Forecast evidence checked November 12, 2026.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.65
- Average price target
- $59.40
- High price target
- $84.00
- Low price target
- $33.00
- Low target gap
- +4.3%
- Target upside
- +87.7%
- High target gap
- +165.4%
- Target range width
- 161.1%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Immunocore Holdings?
Immunocore Holdings has a verified Buy consensus. The same dataset has an average price target of $59.40.
How far are Immunocore Holdings's low and high targets from the recorded price?
The low target implies +4.3%, while the high target implies +165.4%.
How many analysts are included in Immunocore Holdings's consensus?
The verified consensus includes 10 analysts.
How is Immunocore Holdings's target upside or downside calculated?
The average target of $59.40 is divided by the recorded price of $31.65, then one is subtracted to produce +87.7%. This does not guarantee a future return.
When was Immunocore Holdings's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.